{"article_link": "https://www.frontiersin.org/articles/10.3389/fcell.2021.649265/full", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163574", "format": "txt", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE163574"}, {"id": "data_2", "omics": "Proteomics", "link": "https://www.ebi.ac.uk/pride/archive/projects/PXD023344", "format": "raw", "source": "ProteomeXchange", "public_id": "PXD023344"}, {"id": "data_3", "omics": "Phosphoproteomics", "link": "https://www.ebi.ac.uk/pride/archive/projects/PXD023345", "format": "raw", "source": "ProteomeXchange", "public_id": "PXD023345"}, {"id": "data_4", "omics": "Transcriptomics", "link": "https://portal.gdc.cancer.gov/", "format": "bam", "source": "The Cancer Genome Atlas (TCGA)", "public_id": "TCGA_PAAD (Pancreatic Adenocarcinoma)"}, {"id": "data_5", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62452", "format": "txt", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE62452"}, {"id": "data_6", "omics": "Transcriptomics", "link": "https://dcc.icgc.org/", "format": "bam", "source": "International Cancer Genome Consortium (ICGC)", "public_id": "ICGC_AU (Pancreatic Adenocarcinoma)"}], "analyses": [{"id": "analysis_1", "analysis_name": "Transcriptomics", "analysis_data": ["data_1"], "label": {"Condition": ["Anlotinib-treated PANC-1", "DMSO-treated PANC-1"]}}, {"id": "analysis_2", "analysis_name": "Differential analysis", "analysis_data": ["data_1"], "label": {"Condition": ["Anlotinib vs. DMSO"], "Fold change": [">=2"], "FDR": ["<0.05"]}}, {"id": "analysis_3", "analysis_name": "Pathway analysis", "analysis_data": ["analysis_2"], "label": {"Method": ["Pathway analysis via IPA"]}}, {"id": "analysis_4", "analysis_name": "Proteomics", "analysis_data": ["data_2"], "label": {"Fold change": [">1.2"], "p-value": ["<0.05"]}}, {"id": "analysis_5", "analysis_name": "Phosphoproteomics", "analysis_data": ["data_3"], "label": {"Fold change": [">1.2"], "p-value": ["<0.05"]}}, {"id": "analysis_6", "analysis_name": "Integrated multi-omics analysis", "analysis_data": ["analysis_2", "analysis_4", "analysis_5"], "label": {"Integration": ["Transcriptomic, proteomic, and phosphoproteomic"]}}, {"id": "analysis_7", "analysis_name": "Classification analysis", "analysis_data": ["analysis_6", "data_4", "data_5", "data_6"], "label": {"Risk score stratification": ["High vs. Low via LASSO Cox regression"]}}, {"id": "analysis_8", "analysis_name": "Regression analysis", "analysis_data": ["analysis_7"], "label": {"Factors": ["risk score", "N stage"]}}, {"id": "analysis_9", "analysis_name": "Biomarker identification", "analysis_data": ["analysis_6", "data_4", "data_5", "data_6"], "label": {"Biomarkers": ["TOP2A", "CRABP2", "CDK1", "NUSAP1", "PERP"]}}], "results": [{"analysis_id": "analysis_1", "metrics": "IC50", "value": {"PANC-1": "5.535 µM", "AsPC-1": "4.642 µM"}, "features": null}, {"analysis_id": "analysis_2", "metrics": "Number of DEGs", "value": "992", "features": null}, {"analysis_id": "analysis_3", "metrics": "Enriched pathways", "value": "24 cancer-related canonical pathways", "features": ["Unfolded protein response", "Cell cycle: G2/M DNA damage checkpoint regulation", "p53 signaling pathway"]}, {"analysis_id": "analysis_4", "metrics": "Number of differentially expressed proteins", "value": "1046", "features": ["Ribosome", "Lysosome"]}, {"analysis_id": "analysis_5", "metrics": "Number of differentially phosphorylated peptides", "value": "4323", "features": ["Cell cycle", "RNA transport", "Spliceosome"]}, {"analysis_id": "analysis_6", "metrics": "Shared mechanisms", "value": "Post-transcriptional regulation of ribosome and lysosome", "features": ["Ribosome biogenesis", "Lysosomal function"]}, {"analysis_id": "analysis_7", "metrics": "Stratification accuracy", "value": {"GSE62452": "57.7% (37/65)", "ICGC_AU": "57.5% (46/80)"}, "features": ["TOP2A", "CRABP2", "CDK1", "NUSAP1", "PERP"]}, {"analysis_id": "analysis_8", "metrics": "Hazard Ratio (HR)", "value": {"risk score": "2.318", "N stage": "1.831"}, "features": ["risk score", "N stage"]}, {"analysis_id": "analysis_9", "metrics": "AUC", "value": {"TCGA_PAAD": "3 years: 0.7, 5 years: 0.72", "GSE62452": "3 years: 0.87, 5 years: 0.85", "ICGC_AU": "3 years: 0.65, 5 years: 0.75"}, "features": ["TOP2A", "CRABP2", "CDK1", "NUSAP1", "PERP"]}]}